Market Risers: SEGRO plc, Rio Tinto plc, AstraZeneca plc, SSE PLC

Astrazeneca plc
[shareaholic app="share_buttons" id_name="post_below_content"]

Stock in SEGRO plc ticker code: LON:SGRO has stepped up 1.72% or 12.6 points throughout today’s trading session so far. Buyers have stayed positive throughout the trading session. The periods high has already touched 745.6 meanwhile the session low reached 728. The total volume of shares exchanged through this period comes to 539,791 with the daily average number around 2,705,354. The 52 week high is 745.6 equating to 14.8 points difference from the previous days close and putting the 52 week low at 577.6 which is a variance of 153.2 points. SEGRO plc now has a 20 moving average of 711.65 and now its 50 day SMA of 697.9. The current market cap is £8,127.21m at the time of this report. Share price is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for SEGRO plc being recorded at Tuesday, June 18, 2019 at 12:49:48 PM GMT with the stock price trading at 743.4 GBX.

Shares of Rio Tinto plc company symbol: LON:RIO has moved up 1.55% or 74 points during today’s session so far. Traders are a positive bunch during the trading session. The periods high has reached 4877.5 and a low of 4804. The amount of shares exchanged has so far reached 1,046,356 with the average number of shares traded daily being 3,326,468. The 52 week high for the share price is 4877.5 which comes in at 104.5 points difference from the previous days close and putting the 52 week low at 3460 which is a variance of 1313 points. Rio Tinto plc has a 20 SMA of 4683.29 and now a 50 day moving average now at 4624.66. This puts the market capitalisation now at £61,121.90m at the time of this report. The stock is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Rio Tinto plc being recorded at Tuesday, June 18, 2019 at 12:49:36 PM GMT with the stock price trading at 4847 GBX.

The stock price for AstraZeneca plc ticker lookup code: LON:AZN has stepped up 2.42% or 151 points in today’s trading session so far. Traders have so far held a positive outlook during the session. The high for the period has peaked at 6406 while the low for the session was 6267. The volume total for shares traded up to this point was 607,637 whilst the average number of shares exchanged is 2,006,073. The 52 week high for the shares is 6540 amounting to 290 points in difference on the previous days close and a 52 week low being 5110 a difference of some 1140 points. AstraZeneca plc now has a 20 SMA of 6062.89 and also a 50 day simple moving average now of 5980.74. Market capitalisation for the company is £83,966.84m at the time of this report. All share prices mentioned for this stock are traded in GBX. Mcap is measured in GBP. This article was written with the last trade for AstraZeneca plc being recorded at Tuesday, June 18, 2019 at 12:49:44 PM GMT with the stock price trading at 6401 GBX.

Shares in SSE PLC with EPIC code: LON:SSE has risen 2.08% or 23 points throughout the session so far. Investors have remained positive while the stock has been in play. The periods high has already touched 1129.5 while the low for the session was 1101.5. The volume total for shares traded up to this point was 1,125,550 while the daily average number of shares exchanged is 4,298,259. The 52 week high for the shares is 1405 around 299.5 points in difference to the previous days close of business and a 52 week low sitting at 997.8 which is a difference of 107.7 points. SSE PLC now has a 20 SMA of 1087.84 with a 50 day MA at 1114.18. Market capitalisation is now £11,649.06m at the time of this report. All share prices mentioned for this stock are traded in GBX. Mcap is measured in GBP. This article was written with the last trade for SSE PLC being recorded at Tuesday, June 18, 2019 at 12:49:39 PM GMT with the stock price trading at 1128.5 GBX.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    AstraZeneca's Tagrisso gains EU approval for treating advanced NSCLC, showing significant efficacy in reducing disease progression in key trials.
    Rio Tinto appoints Georgie Bezette as Chief People Officer, succeeding James Martin, to lead cultural transformation and talent development from 2025.
    AstraZeneca's Imfinzi receives FDA approval for limited-stage small cell lung cancer, marking a significant breakthrough in extending patient survival.

      Search

      Search